Summary
Updated Aug 30, 2026
Stonepine Capital Management, LLC is 10% Owner of Quoin Pharmaceuticals, Ltd. (QNRX). 1 SEC Form 4 filing on record, dated 31 March 2026.
Trading Pattern
InsiderAlpha's records for Stonepine Capital Management, LLC go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stonepine Capital Management, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dennis Langer - $129K of QNRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Stonepine Capital Management, LLC?
Stonepine Capital Management, LLC is an investment firm, tracked as 10% Owner of Quoin Pharmaceuticals, Ltd. (QNRX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stonepine Capital Management, LLC last file a Form 4?
The only primary Form 4 on record is dated 31 March 2026.
Where can I see all of Stonepine Capital Management, LLC's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stonepine Capital Management, LLC and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial